Are you Dr. Tijani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
602 Indiana Ave
Lubbock, TX 79415Phone+1 806-775-8600Fax+1 806-775-8602
Summary
- Dr. Lukman Tijani, MD is an oncologist in Lubbock, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with University Medical Center and is an Assistant Professor at Texas Tech University Health Science Center School of Medicine.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2007 - 2010
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2000 - 2003
University of Lagos College of MedicineClass of 1988
Certifications & Licensure
TX State Medical License 2018 - 2025
PA State Medical License 2001 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- 20 citationsAnticancer activity of 2'-hydroxyflavanone towards lung cancer.Sanjay Awasthi, Sharad S. Singhal, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Hongzhi Li
Oncotarget. 2018-11-16 - 6 citationsImpact of Primary Ambulatory Thromboprophylaxis (PATP) with Low-Molecular Weight Heparins (LMWHs) on Survival in Patients with Lung Cancer Receiving ChemotherapyKyaw Zin Thein, Donald P. Quick, Thura Win Htut, Lukman Tijani, Thein Hlaing Oo
Lung. 2020-06-01 - 3 citationsIron in blood cells: Function, relation to disease, and potential for magnetic separation.Sowrav Barua, Stefano Ciannella, Lukman Tijani, Jenifer Gomez-Pastora
Biotechnology and Bioengineering. 2023-07-01
